2016
Double blind phase III trial of effects of low dose 13-cisretinoic acid on prevention of second primaries in stages I-II head and neck cancer: A trial of the ECOG-ACRIN Cancer Research Group (C0590).
Bhatia A, Lee J, Pinto H, Jacobs C, Limburg P, Arusell R, Dunphy E, Khandekar J, Reiner S, Baez-Diaz L, Celano P, Li S, Li Y, Burtness B, Pandya K. Double blind phase III trial of effects of low dose 13-cisretinoic acid on prevention of second primaries in stages I-II head and neck cancer: A trial of the ECOG-ACRIN Cancer Research Group (C0590). Journal Of Clinical Oncology 2016, 34: 1507-1507. DOI: 10.1200/jco.2016.34.15_suppl.1507.Peer-Reviewed Original Research
2014
HPV Association and the Increasing Incidence of Unknown Primary Head-and-Neck Squamous Cell Carcinoma Epidemiology and Prevention
Galloway T, Davis K, Burtness B, Ferris R, Mehra R, Ridge J, Flieder D, Duvvuri U. HPV Association and the Increasing Incidence of Unknown Primary Head-and-Neck Squamous Cell Carcinoma Epidemiology and Prevention. International Journal Of Radiation Oncology • Biology • Physics 2014, 88: 494. DOI: 10.1016/j.ijrobp.2013.11.102.Peer-Reviewed Original Research